Net income attributable to common stockholders reached $14.5 million, a 54.3% increase year-over-year. Adjusted EBITDA rose 8.0% to $60.6 million compared to Q1 2025. Adjusted FFO per diluted share grew 15.8% to $0.22. Comparable RevPAR increased 2.0% to $190.01, while Total RevPAR grew 2.5% to $298.95. Comparable Hotel Adjusted EBITDA margin expanded by 127 basis points to 25.63%. The Board authorized a new $300 million share repurchase program.